Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathway

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has been well defined as a common chronic liver metabolism disorder. Statins as a first-line therapeutic treatment had some side effects. Here, we found that Fumigaclavine C (FC) was collected from endophytic Aspergillus terreus via the root of R...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wanguo, Gao, Yaxin, Zhao, Zaoya, Long, Xiufeng, Yi, Yi, Ai, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428638/
https://www.ncbi.nlm.nih.gov/pubmed/37587459
http://dx.doi.org/10.1186/s12906-023-04110-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428638/
https://www.ncbi.nlm.nih.gov/pubmed/37587459
http://dx.doi.org/10.1186/s12906-023-04110-9

Ejemplares similares